17.10.2014 15:27:10
|
Court Grants Covidien Preliminary Injunction Against Ethicon's Harmonic ACE+7
(RTTNews) - Covidien plc (COV) announced Friday that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., a Johnson & Johnson (JNJ) company.
The injunction results from a lawsuit filed by Covidien in June 2014 that alleged Ethicon's latest ultrasonic surgical product, the Harmonic ACE+7, infringes three Covidien patents.
The injunction prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE+7.
The June 2014 lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon's Harmonic ACE+7 Shears. Ethicon's Harmonic devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Covidien Plcmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Covidien Plcmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 157,88 | 0,23% |
|